EPS Creative Health Technology Group Limited (3860.HK)

HKD 0.51

(4.08%)

EBITDA Summary of EPS Creative Health Technology Group Limited

EPS Creative Health Technology Group Limited's latest annual EBITDA in 2023 was -2.96 Million HKD , up 60.81% from previous year.
EPS Creative Health Technology Group Limited's latest quarterly EBITDA in 2023 FY was N/A , up 60.81% from previous quarter.
EPS Creative Health Technology Group Limited reported an annual EBITDA of -37.88 Million HKD in 2022, down -329.22% from previous year.
EPS Creative Health Technology Group Limited reported an annual EBITDA of -14.53 Million HKD in 2021, down -187.13% from previous year.
EPS Creative Health Technology Group Limited reported a quarterly EBITDA of -2.55 Million HKD for 2023 Q1, up 92.85% from previous quarter.
EPS Creative Health Technology Group Limited reported a quarterly EBITDA of -5.56 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of EPS Creative Health Technology Group Limited (2023 - 2014)

Historical Annual EBITDA of EPS Creative Health Technology Group Limited (2023 - 2014)

Year	EBITDA	EBITDA Growth
2023	-2.96 Million HKD	60.81%
2022	-37.88 Million HKD	-329.22%
2021	-14.53 Million HKD	-187.13%
2020	10.31 Million HKD	-66.41%
2019	30.15 Million HKD	-11.1%
2018	33.91 Million HKD	83.76%
2017	18.45 Million HKD	75.26%
2016	10.53 Million HKD	-44.29%
2015	22.76 Million HKD	12.04%
2014	16.61 Million HKD	0.0%

Year	EBITDA	EBITDA Growth
2023 FY	- HKD	60.81%
2023 Q1	-2.55 Million HKD	92.85%
2023 Q4	-5.56 Million HKD	0.0%
2023 Q3	-5.56 Million HKD	62.87%
2023 Q2	-14.98 Million HKD	-487.3%
2022 Q4	-35.65 Million HKD	-111.55%
2022 FY	- HKD	-329.22%
2022 Q3	-16.85 Million HKD	-757.35%
2022 Q2	-1.96 Million HKD	45.99%
2022 Q1	-3.64 Million HKD	35.52%
2021 Q1	-1.88 Million HKD	-152.69%
2021 Q3	-4.06 Million HKD	-243.7%
2021 Q2	-1.18 Million HKD	37.23%
2021 FY	- HKD	-187.13%
2021 Q4	-5.64 Million HKD	-38.95%
2020 Q2	5.22 Million HKD	142.64%
2020 Q4	3.57 Million HKD	136.06%
2020 Q3	1.51 Million HKD	-71.02%
2020 FY	- HKD	-66.41%
2020 Q1	2.15 Million HKD	-74.37%
2019 Q2	26.62 Million HKD	854.36%
2019 FY	- HKD	-11.1%
2019 Q3	4.41 Million HKD	-83.43%
2019 Q1	-3.53 Million HKD	-3702.04%
2019 Q4	8.39 Million HKD	90.37%
2018 Q1	-6.98 Million HKD	-199.02%
2018 FY	- HKD	83.76%
2018 Q4	98 Thousand HKD	-99.48%
2018 Q3	18.93 Million HKD	-8.96%
2018 Q2	20.79 Million HKD	397.57%
2017 FY	- HKD	75.26%
2017 Q3	8.89 Million HKD	-0.07%
2017 Q4	7.05 Million HKD	-20.68%
2017 Q1	-7.39 Million HKD	-3082.66%
2017 Q2	8.9 Million HKD	220.36%
2016 Q3	8.96 Million HKD	7.47%
2016 FY	- HKD	-44.29%
2016 Q4	248 Thousand HKD	-97.23%
2016 Q1	-7.8 Million HKD	0.0%
2016 Q2	8.33 Million HKD	206.88%
2015 FY	- HKD	12.04%
2014 FY	- HKD	0.0%

Peer EBITDA Comparison of EPS Creative Health Technology Group Limited

Name	EBITDA	EBITDA Difference
ENM Holdings Limited	-5.85 Million HKD	49.42%
Esprit Holdings Limited	-1.83 Billion HKD	99.839%
Bossini International Holdings Limited	-224.53 Million HKD	98.68%
Giordano International Limited	994 Million HKD	100.298%
Symphony Holdings Limited	-22.98 Million HKD	87.11%
Forward Fashion (International) Holdings Company Limited	165.93 Million HKD	101.786%